Management

Martin Latterich, Ph.D.

Vice President of Technical Operations & Member of the OTC

Dr. Latterich is a biotechnology executive with a strong mix of business and academic experience. Currently also serving as CSO of ProterixBio (formerly BioScale), Inc., his past professional affiliations include the Salk Institute as Assistant Professor, Diversa (NASDAQ: VRNM) as Principal Scientist, Illumina (NASDAQ: ILMN) as Director of Proteomics, McGill Medical School and the University of Montreal as Associate Professor, the Proteogenomics Research Institute for Systems Medicine as Professor and the Nicholas Conor Institute as founding CEO and CSO.

Dr. Latterich brings expertise and strength in the establishment and growth of science-focused research organizations, team-building, corporate scientific leadership and external collaborations and partnerships. He is author of 39 publications and one book, and has served as Editor-in-Chief of Proteome Science since 2002. He has been the recipient of grant funding from NIH, HFSP, March of Dimes, Pew Foundation, Genome Canada, Genome Quebec, CIHR and CFI. Dr. Latterich is a 1998 Pew Scholar and has held a Tier I Canada Research Chair at McGill University. He performed post-doctoral training in the laboratory of the Nobel Laureate Randy Schekman at UC Berkeley.